Similar articles

• Preliminary 1H NMR investigation of sialic acid transfer by the trans-sialidase from Trypanosoma cruzi.

  Wilson JC, Kiefel MJ, Albouz-Abo S, von Itzstein M. Wilson JC, et al. Bioorg Med Chem Lett. 2000 Dec 18;10(24):2791-4. doi: 10.1016/s0960-894x(00)00572-2. Bioorg Med Chem Lett. 2000. PMID: 11133093
• Structural and functional properties of Trypanosoma trans-sialidase.

  Schenkman S, Eichinger D, Pereira ME, Nussenzweig V. Schenkman S, et al. Annu Rev Microbiol. 1994;48:499-523. doi: 10.1146/annurev.mi.48.100194.002435. Annu Rev Microbiol. 1994. PMID: 7826016 Review.
• The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase.

  Gallant JP, Lima-Cordón RA, Justi SA, Monroy MC, Viola T, Stevens L. Gallant JP, et al. Infect Genet Evol. 2018 Aug;62:151-159. doi: 10.1016/j.meegid.2018.04.025. Epub 2018 Apr 21. Infect Genet Evol. 2018. PMID: 29684709 Free PMC article.
• Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi.

  Colli W. Colli W. FASEB J. 1993 Oct;7(13):1257-64. doi: 10.1096/fasebj.7.13.8405811. FASEB J. 1993. PMID: 8405811 Review.
• Sialic acid acceptors of different stages of Trypanosoma cruzi are mucin-like glycoproteins linked to the parasite membrane by GPI anchors.

  Acosta A, Schenkman RP, Schenkman S. Acosta A, et al. Braz J Med Biol Res. 1994 Feb;27(2):439-42. Braz J Med Biol Res. 1994. PMID: 8081262